Concepedia

Sophie H. Nock

SH

4

Publications

268

Citations

4

H-Index

2017

Active since

Affiliations

University of Reading(Current)

Queen Elizabeth Hospital Birmingham

University of Birmingham

Heartlands Hospital

Sophie H. Nock is an author at University of Reading specializing in molecular signaling, signal transduction, and drug discovery.

ORCID

Top concepts

Publications per year

2017–2020

4

Publications

4

Severe platelet dysfunction in NHL patients receiving ibrutinib is absent in patients receiving acalabrutinib

Alexander P. Bye, Amanda J. Unsworth, Michael Desborough et al. · Blood Advances · 2017 · 123 citations · Full text

Inhibition of Btk by Btk-specific concentrations of ibrutinib and acalabrutinib delays but does not block platelet aggregation mediated by glycoprotein VI

Phillip L.R. Nicolson, Craig E. Hughes, Stephanie L. Watson et al. · Haematologica · 2018 · 70 citations · Full text

Low-dose Btk inhibitors selectively block platelet activation by CLEC-2

Phillip L.R. Nicolson, Sophie H. Nock, Joshua Hinds et al. · Haematologica · 2020 · 60 citations · Full text

, , +18

Zafirlukast is a broad‐spectrum thiol isomerase inhibitor that inhibits thrombosis without altering bleeding times

Lisa‐Marie Holbrook, Shirley Keeton, Parvathy Sasikumar et al. · British Journal of Pharmacology · 2020 · 15 citations · Full text

Rows per page

1–4 of 4